Search
Descriptor English: Ibandronic Acid
Descriptor Spanish: Ácido Ibandrónico
Descriptor ácido ibandrónico
Entry term(s) (1-hidroxi-3-(metilpentilamino)propiliden)bisfosfonato
1-hidroxi-3-(metilpentilamino)propilidenbisfosfonato
BM 21.0955
BM 210955
BM-21.0955
BM-210955
BM21.0955
BM210955
Bondronat
Boniva
Bonviva
RPR 102289A
RPR-102289A
RPR102289A
ibandronato
ibandronato de sodio
ibandronato de sodio anhidro
ibandronato sódico
ibandronato sódico anhidro
sal sódica monohidratada del ácido ibandrónico
Scope note: Aminobisfosfonato que es un potente inhibidor de la RESORCIÓN ÓSEA. Se usa en el tratamiento de la HIPERCALCEMIA asociada a neoplasias malignas, para la prevención de las fracturas y las complicaciones óseas en pacientes con cáncer de mama y metástasis óseas y para el tratamiento y la prevención de la OSTEOPOROSIS POSMENOPÁUSICA.
Descriptor Portuguese: Ácido Ibandrônico
Descriptor French: Acide ibandronique
Entry term(s): (1-Hydroxy-3-(methylpentylamino)propylidene)bisphosphonate
1-Hydroxy-3-(methylpentylamino)propylidenebisphosphonate
BM 21.0955
BM 210955
BM-21.0955
BM-210955
BM21.0955
BM210955
Bondronat
Boniva
Bonviva
Ibandronate
Ibandronate Sodium
Ibandronate Sodium Anhydrous
Ibandronic Acid, Sodium Salt, Monohydrate
RPR 102289A
RPR-102289A
RPR102289A
Tree number(s): D02.705.429.500.844
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000077557
Scope note: Aminobisphosphonate that is a potent inhibitor of BONE RESORPTION. It is used in the treatment of HYPERCALCEMIA associated with malignancy, for the prevention of fracture and bone complications in patients with breast cancer and bone metastases, and for the treatment and prevention of POSTMENOPAUSAL OSTEOPOROSIS.
Allowable Qualifiers: AA analogs & derivatives
AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
EC economics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UR urine
Pharm Action: Bone Density Conservation Agents
Registry Number: UMD7G2653W
CAS Type 1 Name: Phosphonic acid, (1-hydroxy-3-(methylpentylamino)propylidene)bis-
Public MeSH Note: 2019; IBANDRONIC ACID was indexed under DIPHOSPHONATES 1992-2018
History Note: 2019 (1992)
DeCS ID: 57682
Unique ID: D000077557
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2019/01/01
Date of Entry: 2018/07/09
Revision Date: 2018/07/03
Ibandronic Acid - Preferred
Concept UI M0197524
Scope note Aminobisphosphonate that is a potent inhibitor of BONE RESORPTION. It is used in the treatment of HYPERCALCEMIA associated with malignancy, for the prevention of fracture and bone complications in patients with breast cancer and bone metastases, and for the treatment and prevention of POSTMENOPAUSAL OSTEOPOROSIS.
Preferred term Ibandronic Acid
Ibandronate - Narrower
Concept UI M0197523
Preferred term Ibandronate
Entry term(s) (1-Hydroxy-3-(methylpentylamino)propylidene)bisphosphonate
1-Hydroxy-3-(methylpentylamino)propylidenebisphosphonate
Ibandronate Sodium Anhydrous - Narrower
Concept UI M000640937
Preferred term Ibandronate Sodium Anhydrous
Boniva - Narrower
Concept UI M0500201
Preferred term Boniva
Bonviva - Narrower
Concept UI M0374853
Preferred term Bonviva
Ibandronate Sodium - Narrower
Concept UI M000629520
Preferred term Ibandronate Sodium
Entry term(s) Ibandronic Acid, Sodium Salt, Monohydrate
RPR 102289A - Narrower
Concept UI M0374852
Preferred term RPR 102289A
Entry term(s) RPR-102289A
RPR102289A
Bondronat - Narrower
Concept UI M0374854
Preferred term Bondronat
BM 21.0955 - Narrower
Concept UI M0197520
Preferred term BM 21.0955
Entry term(s) BM 210955
BM-21.0955
BM-210955
BM21.0955
BM210955



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey